US grocery chain offers Home Diagnostics' glucose meters
This article was originally published in Clinica
Executive Summary
US grocer Wegmans Food Markets is launching its first glucose monitoring systems for diabetics, TRUEresult and TRUE2go. The monitors will carry the shop's branding and will be supplied by Nipro Diagnostics (previously Home Diagnostics), which originally developed the device. The launch reflects a trend towards greater availability of point-of-care tests outside the conventional settings such as hospitals or doctors' surgeries, and the direct targeting of consumers by IVD companies. This segment is expected to grow as it offers consumers greater convenience. TRUEresult and TRUE2go received 510(k) clearance from the US FDA in 2008 (www.clinica.co.uk, 21 August 2010). TRUEresult will be sold in Wegmans for $19.99 and the smaller TRUE2go device for $8.99. Wegmans operates 77 stores in New York, Pennsylvania, New Jersey, Virginia and Maryland.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.